ORASURE TECHNOLOGIES INC's gross profit margin for the third quarter of its fiscal year 2014 has increased when compared to the same period a year ago. Sales and net income have grown, and although the growth in revenues has outpaced the average competitor within the industry, the net income growth has not. ORASURE TECHNOLOGIES INC is extremely liquid. Currently, the Quick Ratio is 4.51 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year.
At the same time, stockholders' equity ("net worth") has remained virtually unchanged only increasing by 3.89% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q3 FY14||Q3 FY13|
|Net Sales ($mil)||27.85||24.67|
|Net Income ($mil)||1.14||-1.89|
|Balance Sheet||Q3 FY14||Q3 FY13|
|Cash & Equiv. ($mil)||98.86||82.59|
|Total Assets ($mil)||190.5||178.21|
|Total Debt ($mil)||0.0||0.0|
|Profitability||Q3 FY14||Q3 FY13|
|Gross Profit Margin||73.01||67.12|
|Return on Assets||2.23||-13.05|
|Return on Equity||2.64||-15.02|
|Debt||Q3 FY14||Q3 FY13|
|Share Data||Q3 FY14||Q3 FY13|
|Shares outstanding (mil)||56.05||55.6|
|Div / share||0.0||0.0|
|Book value / share||2.87||2.79|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||506325.0||554016.0|
HOLD. ORASURE TECHNOLOGIES INC's P/E ratio indicates a significant premium compared to an average of 41.01 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 19.41. Conducting a second comparison, its price-to-book ratio of 3.49 indicates a premium versus the S&P 500 average of 2.74 and a significant discount versus the industry average of 5.04. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average.
|OSUR 143.29||Peers 41.01||OSUR 28.11||Peers 30.45|
Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.
OSUR is trading at a significant premium to its peers.
Average. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
OSUR is trading at a valuation on par to its peers.
|OSUR 1003.00||Peers 26.32||OSUR NM||Peers 1.42|
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.
OSUR's ratio is negative making this valuation measure meaningless.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
OSUR's negative PEG ratio makes this valuation measure meaningless.
|OSUR 3.49||Peers 5.04||OSUR 116.66||Peers 22.55|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
OSUR is trading at a significant discount to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
OSUR is expected to have an earnings growth rate that significantly exceeds its peers.
|OSUR 5.40||Peers 7.01||OSUR 12.71||Peers 7.56|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
OSUR is trading at a discount to its industry on this measurement.
Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.
OSUR has a sales growth rate that significantly exceeds its peers.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV